Are monocytes a preferable option to develop myeloid cell-based therapies for solid tumors?
Abstract In the last two decades, novel and promising cell-based therapies have populated the treatment landscape for haematological tumors. However, commonly exploited T and NK cell-based therapies show limited applicability to solid tumors. This is mainly given by the impaired tumor trafficking ca...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2025-03-01
|
| Seri Bilgileri: | Journal of Experimental & Clinical Cancer Research |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s13046-025-03359-x |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|